Anika Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ANIK Nasdaq 2836 www.anika.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anika Therapeutics, Inc.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 5th, 2026 3:00 pm
President of Anika Therapeutics Picks Up 51% More Stock - May 3rd, 2026 7:36 am
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues - Apr 30th, 2026 2:43 pm
Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary - Apr 29th, 2026 10:50 am
Anika Therapeutics Q1 Earnings Call Highlights - Apr 29th, 2026 8:20 am
Anika Reports First Quarter 2026 Financial Results - Apr 29th, 2026 5:05 am
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors - Apr 16th, 2026 5:30 am
Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026 - Apr 15th, 2026 2:01 pm
Telix Strengthens Board with Additional Director Appointments - Apr 8th, 2026 4:44 pm
Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization - Apr 7th, 2026 1:35 pm
Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK Conference - Mar 3rd, 2026 1:29 am
Anika Therapeutics, Inc. Q4 2025 Earnings Call Summary - Feb 27th, 2026 6:30 am
Anika Therapeutics Inc (ANIK) Q4 2025 Earnings Call Highlights: Strong International Growth and ... - Feb 26th, 2026 2:09 pm
Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates - Feb 26th, 2026 10:15 am
Anika Therapeutics Q4 Earnings Call Highlights - Feb 26th, 2026 8:59 am
Anika: Q4 Earnings Snapshot - Feb 26th, 2026 5:35 am
Anika Reports Fourth Quarter and Full Year 2025 Financial Results - Feb 26th, 2026 5:05 am
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference - Feb 18th, 2026 2:01 pm
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026 - Feb 12th, 2026 2:01 pm
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors - Feb 4th, 2026 6:54 am